- The KMT2A recombinome of acute leukemias in 20232023 | Second Faculty of Medicine
- Rearrangement of KMT2A Characterizes a Subset of Pediatric Parotid Mucoepidermoid Carcinomas Arising Metachronous to Acute Lymphoblastic Leukemia2023 | Faculty of Medicine in Pilsen
- Outcome of infants younger than 1 year with acute lymphoblastic leukemia treated with the interfant-06 protocol: Results from an international phase III randomized study2019 | Second Faculty of Medicine
- Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol2021 | Second Faculty of Medicine
- Long-term remission of therapy-related acute myeloid leukemia with a new t(11;18)(q23;q21.2) translocation and KMT2A-ME2 (MLL-ME2) fusion gene2015 | Second Faculty of Medicine
- KMT2B Is Selectively Required for Neuronal Transdifferentiation, and Its Loss Exposes Dystonia Candidate Genes2018 | First Faculty of Medicine
- Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma2019 | Second Faculty of Medicine
- Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study2016 | Second Faculty of Medicine
- Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study2024 | Second Faculty of Medicine